Filed with the SEC on · Summarized by InvestorsBot
Gilead Sciences Chief Communications and Corporate Affairs Officer Johanna Mercier sold 16,530 shares at $137.37 each for approximately $2.27 million and 11,470 shares at $138.04 each for approximately $1.58 million on Aug. 17. She owned 129,704 shares after the first sale and 118,234 shares after the second.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeGilead CEO Daniel O'Day sells $2.2M in stock
Form 4 · Insider Trade · September 2, 2026
Gilead director Anthony Welters sells $2.7M in stock
Form 4 · Insider Trade · August 27, 2026
Gilead reports 10% revenue growth but widens 2026 loss guidance
8-K · August 4, 2026
Gilead CEO Daniel O’Day sells about $2.0M in stock
Form 4 · Insider Trade · August 4, 2026
Gilead filed exhibits re: an acquisition — Agreement & Plan of Merger (dated Feb 22, 2026) among Gilead,…
8-K · February 23, 2026
Feb 23, 2026: $GILD and $ACLX announced they signed a Merger Agreement and the FDA accepted the BLA for…
8-K · February 23, 2026